JB
The startup develops nerve tissue products and screening technology to identify neurodegenerative diseases, including Amyotrophic Lateral Sclerosis. Their approach includes creating nerve tissue transplants that closely mimic human tissue, enabling targeted treatments for these disorders.
Updated 3 months ago
Funding
$7.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops nerve tissue products and screening technology to identify neurodegenerative diseases, including Amyotrophic Lateral Sclerosis. Their approach includes creating nerve tissue transplants that closely mimic human tissue, enabling targeted treatments for these disorders.